These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 19303570)

  • 21. Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial.
    Gerding DN; Meyer T; Lee C; Cohen SH; Murthy UK; Poirier A; Van Schooneveld TC; Pardi DS; Ramos A; Barron MA; Chen H; Villano S
    JAMA; 2015 May; 313(17):1719-27. PubMed ID: 25942722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of antimicrobial activity of ceftaroline against Clostridium difficile and propensity to induce C. difficile infection in an in vitro human gut model.
    Baines SD; Chilton CH; Crowther GS; Todhunter SL; Freeman J; Wilcox MH
    J Antimicrob Chemother; 2013 Aug; 68(8):1842-9. PubMed ID: 23557928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Passive immunisation of hamsters against Clostridium difficile infection using antibodies to surface layer proteins.
    O'Brien JB; McCabe MS; Athié-Morales V; McDonald GS; Ní Eidhin DB; Kelleher DP
    FEMS Microbiol Lett; 2005 May; 246(2):199-205. PubMed ID: 15899406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oritavancin does not induce Clostridium difficile germination and toxin production in hamsters or a human gut model.
    Freeman J; Marquis M; Crowther GS; Todhunter SL; Fawley WN; Chilton CH; Moeck G; Lehoux D; Wilcox MH
    J Antimicrob Chemother; 2012 Dec; 67(12):2919-26. PubMed ID: 22899803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colonisation with digoxin-reducing strains of Eubacterium lentum and Clostridium difficile infection in nursing home patients.
    Bennett RG; Beamer BA; Greenough WB; Lindenbaum J; Bartlett JG
    J Diarrhoeal Dis Res; 1992 Jun; 10(2):87-92. PubMed ID: 1500644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-dose cefuroxime with gentamicin reduces Clostridium difficile-associated disease in hip-fracture patients.
    Starks I; Ayub G; Walley G; Orendi J; Roberts P; Maffulli N
    J Hosp Infect; 2008 Sep; 70(1):21-6. PubMed ID: 18621442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clostridium difficile spore germination: an update.
    Burns DA; Heap JT; Minton NP
    Res Microbiol; 2010 Nov; 161(9):730-4. PubMed ID: 20863888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infection control measures to limit the spread of Clostridium difficile.
    Vonberg RP; Kuijper EJ; Wilcox MH; Barbut F; Tüll P; Gastmeier P; ; ; van den Broek PJ; Colville A; Coignard B; Daha T; Debast S; Duerden BI; van den Hof S; van der Kooi T; Maarleveld HJ; Nagy E; Notermans DW; O'Driscoll J; Patel B; Stone S; Wiuff C
    Clin Microbiol Infect; 2008 May; 14 Suppl 5():2-20. PubMed ID: 18412710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clostridium difficile--a spectrum of virulence and analysis of putative virulence determinants in the hamster model of antibiotic-associated colitis.
    Borriello SP; Ketley JM; Mitchell TJ; Barclay FE; Welch AR; Price AB; Stephen J
    J Med Microbiol; 1987 Aug; 24(1):53-64. PubMed ID: 3612744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of biotherapeutics on cyclosporin-induced Clostridium difficile infection in mice.
    Kaur S; Vaishnavi C; Ray P; Kochhar R; Prasad KK
    J Gastroenterol Hepatol; 2010 Apr; 25(4):832-8. PubMed ID: 20074161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.
    Gavaldá J; Onrubia PL; Gómez MT; Gomis X; Ramírez JL; Len O; Rodríguez D; Crespo M; Ruíz I; Pahissa A
    J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active immunization of hamsters against Clostridium difficile infection using surface-layer protein.
    Ní Eidhin DB; O'Brien JB; McCabe MS; Athié-Morales V; Kelleher DP
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):207-18. PubMed ID: 18093141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clostridium difficile: prevalence in horses and environment, and antimicrobial susceptibility.
    Båverud V; Gustafsson A; Franklin A; Aspán A; Gunnarsson A
    Equine Vet J; 2003 Jul; 35(5):465-71. PubMed ID: 12875324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model.
    Ochsner UA; Bell SJ; O'Leary AL; Hoang T; Stone KC; Young CL; Critchley IA; Janjic N
    J Antimicrob Chemother; 2009 May; 63(5):964-71. PubMed ID: 19251726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative study of thermoresistance spores of Clostridium difficile strains belonging to different toxigenicity groups].
    Wultańska D; Pituch H; Obuch-Woszczatyński P; Meisel-Mikołajczyk F; Luczak M
    Med Dosw Mikrobiol; 2004; 56(2):155-9. PubMed ID: 15544087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic associated diarrhoea and enterocolitis.
    Vaishnavi C
    Trop Gastroenterol; 1997; 18(4):145-8. PubMed ID: 9612093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridium difficile ribotypes 027 and 106: clinical outcomes and risk factors.
    Sundram F; Guyot A; Carboo I; Green S; Lilaonitkul M; Scourfield A
    J Hosp Infect; 2009 Jun; 72(2):111-8. PubMed ID: 19386381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tigecycline does not induce proliferation or cytotoxin production by epidemic Clostridium difficile strains in a human gut model.
    Baines SD; Saxton K; Freeman J; Wilcox MH
    J Antimicrob Chemother; 2006 Nov; 58(5):1062-5. PubMed ID: 17030519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo activities of nitazoxanide against Clostridium difficile.
    McVay CS; Rolfe RD
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2254-8. PubMed ID: 10952564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative efficacy of ampicillin, chloramphenicol, cefotaxime, ceftriaxone and pefloxacin in experimental Salmonella typhimurium infection].
    Nauciel C; Martin E
    Pathol Biol (Paris); 1987 Nov; 35(9):1239-42. PubMed ID: 3320900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.